中枢肥胖症和心肺代谢疾病之间的机制联系
Saif Al-Chalabi1,2, Akheel A Syed3,4, Philip A Kalra5,3
1Department of Renal Medicine, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK, alchalabi01@gmail.com.
Cardiorenal medicine
|January 3, 2024
概括
中枢肥胖症显著导致心脏和脏代谢疾病. 通过改变生活方式和药物治疗来准中心肥胖症对于减少疾病负担和改善健康结果至关重要.
科学领域:
- 代谢性疾病研究研究.
- 肥胖研究的研究.
- 心脏病的健康状况.
背景情况:
- 全球肥胖率急剧上升,导致心代谢性疾病增加,如2型糖尿病,慢性病和心力衰竭.
- 影响全球41.5%的中部肥胖症,即使在正常的体重指数下也会带来风险,并且与不良健康结果有关.
- 心脏代谢性疾病经常聚集在中部肥胖的个体中,增加死亡率和医疗负担.
研究的目的:
- 调查将中心肥胖与心代谢疾病联系在一起的病理生理路径.
- 探索中心肥胖症作为心脏脏代谢疾病的常见致病因素的作用.
- 确定潜在的治疗点,以减轻与肥胖相关的心脏和脏代谢疾病.
主要方法:
- 关于肥胖和心神经代谢疾病的当前科学文献的综述.
- 分析将中心肥胖与疾病发展联系起来的病理生理机制.
- 检查影响中心肥胖易感性的因素.
主要成果:
- 中心肥胖是心脏病代谢疾病发展的关键因素.
- 确定的途径包括氨酸- ангиотензин- алдостерон系统激活,交感神经系统过度活跃,炎症,氧化应激,血动力学损伤,胰岛素耐药性和内皮功能障碍.
- 证据支持SGLT2抑制剂和GLP-1受体激动剂在心脏病保护和减肥方面的有效性.
结论:
- 中枢肥胖症在心代谢疾病的发病过程中起着至关重要的作用.
- 基于人口的策略,包括饮食和生活方式干预措施,对于管理中心肥胖症至关重要.
- 针对中心肥胖症的药物治疗开发对于减少心脏脏代谢疾病的全球负担至关重要.
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:24Obesity
507
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
507
01:18Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
01:18Neural Regulation of Blood Pressure
2.8K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
2.8K
01:22Heart Failure Drugs: Diuretics
388
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388